<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03077399</url>
  </required_header>
  <id_info>
    <org_study_id>38RC16.088</org_study_id>
    <nct_id>NCT03077399</nct_id>
  </id_info>
  <brief_title>Validation Study of SCALA, Scale for Lateropulsion</brief_title>
  <acronym>SCALA</acronym>
  <official_title>Clinical Validation of SCALA, a New Rating Scale for Assessing Lateropulsion After Stroke</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Grenoble</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Grenoble</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Development and clinical validation of SCALA, a new rating scale for lateropulsion after
      stroke. A monocentric controlled study including 60 patients post-stroke and 40 patients
      without stroke and/or healthy volunteers..

      In order to analyze the SCALA's content validity, a Delphi-type consensus process will be
      applied prior to clinical validation. The Delphi process, including 20 international experts,
      will give rise to the version of the scale to be tested clinically.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The protocol aims to develop and validate a new clinical rating scale assessing lateropulsion
      after stroke. The project is driven by the need to have a tool that better meets clinimetric
      properties than the 2 main existing scales, the Scale for Contraversive Pushing (SCP) and the
      Burke Lateropulsion Scale (BLS).

      The initial version (version 0) of the scale has been developped by our team in Grenoble.

      In a first step, an online expert consensus process (Delphi method) will give rise to a
      version 1, considered as generally accepted by the scientific community.

      The SCALA version 1 will be validated in a monocentric clinical study. 60 patients and 40
      patients without stroke and/or healthy controls will be included.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 2020</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Anticipated">September 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>SCALA validation</measure>
    <time_frame>60d</time_frame>
    <description>Reliability and internal consistency of SCALA</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evaluation of SCALA sensitivity</measure>
    <time_frame>60d</time_frame>
    <description>application of Scale at different time ponts (from d30 to d90)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Stroke</condition>
  <arm_group>
    <arm_group_label>stroke</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>stroke patients, application of SCALA</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patients without stroke, application of SCALA</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>SCALA</intervention_name>
    <description>All items of SCALA are applied</description>
    <arm_group_label>control</arm_group_label>
    <arm_group_label>stroke</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        post stroke (&lt;30d)

        Exclusion Criteria:

        neurological conditions interfering with balance acute vertigo postural asymmetry or
        scoliosis for reasons other than stroke
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dominic Pérennou</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Grenoble</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Dominic Pérennou, MD, PhD</last_name>
    <phone>0033 4 76767575</phone>
    <email>akistner@chu-grenoble.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Andrea Kistner, PhD</last_name>
    <phone>0033 4 76767575</phone>
    <email>akistner@chu-grenoble.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Grenoble University Hospital</name>
      <address>
        <city>Grenoble</city>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Dominic Pérennou, MD, PhD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>October 7, 2016</study_first_submitted>
  <study_first_submitted_qc>March 6, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 13, 2017</study_first_posted>
  <last_update_submitted>March 19, 2020</last_update_submitted>
  <last_update_submitted_qc>March 19, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 23, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>lateropulsion</keyword>
  <keyword>stroke</keyword>
  <keyword>Pusher syndrome</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

